Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Akiyuki Osawa"'
Autor:
Yuma Aoki, Akiyoshi Kinoshita, Akiyuki Osawa, Tomohiro Kano, Yuko Sato, Yuki Mitsuyoshi, Kazuhiko Koike, Masayuki Saruta
Publikováno v:
Kanzo. 63:196-202
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0499f443e4cf5f81955f1ead69307645
https://doi.org/10.2957/kanzo.63.196
https://doi.org/10.2957/kanzo.63.196
Autor:
Akiyoshi Kinoshita, Noriko Hagiwara, Akiyuki Osawa, Takafumi Akasu, Yoshihiro Matsumoto, Kaoru Ueda, Chisato Saeki, Tsunekazu Oikawa, Kazuhiko Koike, Masayuki Saruta
Publikováno v:
Journal of Oncology Pharmacy Practice. 29:626-636
Introduction Management of elderly patients with cancer has become a global issue. We investigated the safety and tolerability of lenvatinib in hepatocellular carcinoma (HCC) patients ≥80 years old. Methods We retrospectively evaluated 61 HCC patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1df112aaabe4c81b189346bc8d011dd3
https://doi.org/10.1177/10781552221077039
https://doi.org/10.1177/10781552221077039
Autor:
Akiyoshi, Kinoshita, Noriko, Hagiwara, Akiyuki, Osawa, Takafumi, Akasu, Yoshihiro, Matsumoto, Kaoru, Ueda, Chisato, Saeki, Tsunekazu, Oikawa, Kazuhiko, Koike, Masayuki, Saruta
Publikováno v:
In Vivo
Background/Aim: We aimed to investigate the association between The Geriatric Nutritional Risk Index (GNRI) and the tolerability of lenvatinib in patients with hepatocellular carcinoma (HCC). Patients and Methods: We retrospectively evaluated 61 HCC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d044a795919371e2d596f3e194740f7
https://doi.org/10.21873/invivo.12775
https://doi.org/10.21873/invivo.12775
Autor:
Kinoshita, Akiyoshi, Hagiwara, Noriko, Osawa, Akiyuki, Akasu, Takafumi, Matsumoto, Yoshihiro, Ueda, Kaoru, Saeki, Chisato, Oikawa, Tsunekazu, Koike, Kazuhiko, Saruta, Masayuki
Publikováno v:
Journal of Oncology Pharmacy Practice; Apr2023, Vol. 29 Issue 3, p626-636, 11p